The Cost Outcome Pathway Framework: Integrating socio-economic impacts to Adverse Outcome Pathways
View ORCID ProfileThibaut Coustillet, View ORCID ProfileXavier Coumoul, View ORCID ProfileAnne-Sophie Villégier, Michèle Bisson, View ORCID ProfileEllen Fritsche, View ORCID ProfileJean-Marc Brignon, View ORCID ProfileFlorence Zeman, View ORCID ProfileKarine Audouze
doi: https://doi.org/10.1101/2024.02.20.24303098
Thibaut Coustillet
1Université Paris Cité, INSERM UMR-S 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, FRANCE
Xavier Coumoul
1Université Paris Cité, INSERM UMR-S 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, FRANCE
Anne-Sophie Villégier
2Institut National de l’Environnement Industriel et des Risques (INERIS), Unité Toxicologie Expérimentale et Modélisation (TEAM), Parc ALATA BP2, 60550, Verneuil-en-Halatte, FRANCE
3PériTox, UMR_I 01, CURS, Université de Picardie Jules Verne, Chemin du Thil, 80025, Amiens, FRANCE
Michèle Bisson
4Unité d’Expertise en Toxicologie/Ecotoxicologie des Substances, Institut National de l’Environnement Industriel et des Risques, 60550, Verneuil-en-Halatte, FRANCE
Ellen Fritsche
5IUF – Leibniz Research Institute for Environmental Medicine, Duesseldorf, GERMANY
6Medical Faculty, Heinrich-Heine-University, Duesseldorf, GERMANY
7DNTOX GmbH, Duesseldorf, GERMANY
Jean-Marc Brignon
2Institut National de l’Environnement Industriel et des Risques (INERIS), Unité Toxicologie Expérimentale et Modélisation (TEAM), Parc ALATA BP2, 60550, Verneuil-en-Halatte, FRANCE
Florence Zeman
2Institut National de l’Environnement Industriel et des Risques (INERIS), Unité Toxicologie Expérimentale et Modélisation (TEAM), Parc ALATA BP2, 60550, Verneuil-en-Halatte, FRANCE
3PériTox, UMR_I 01, CURS, Université de Picardie Jules Verne, Chemin du Thil, 80025, Amiens, FRANCE
Karine Audouze
1Université Paris Cité, INSERM UMR-S 1124 T3S, 45 rue des Saints-Pères, 75006, Paris, FRANCE

- supplementary[supplements/303098_file02.pdf]
Posted February 21, 2024.
The Cost Outcome Pathway Framework: Integrating socio-economic impacts to Adverse Outcome Pathways
Thibaut Coustillet, Xavier Coumoul, Anne-Sophie Villégier, Michèle Bisson, Ellen Fritsche, Jean-Marc Brignon, Florence Zeman, Karine Audouze
medRxiv 2024.02.20.24303098; doi: https://doi.org/10.1101/2024.02.20.24303098
The Cost Outcome Pathway Framework: Integrating socio-economic impacts to Adverse Outcome Pathways
Thibaut Coustillet, Xavier Coumoul, Anne-Sophie Villégier, Michèle Bisson, Ellen Fritsche, Jean-Marc Brignon, Florence Zeman, Karine Audouze
medRxiv 2024.02.20.24303098; doi: https://doi.org/10.1101/2024.02.20.24303098
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)